Ian S Mitchell

This inventor holds 33 USPTO granted patents and 15 published patent applications, plus 9 CIPO patents and 14 EPO patents, primarily in Akt Protein Kinase Inhibitors. Top assignees: Array Biopharma Inc., Genentech, Inc., Bristol-Myers Squibb Pharma Company. Active years: 2003-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ian S Mitchell. Retrieved from https://idiyas.com/inventor/ian-s-mitchell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 15)

% Patents Active = 87.9

CIPO Patents = 9

EPO Patents = 14 (Patent Applications = 10)

Average Co-Inventor Count = 8.4

ph-index = 15

Forward Citations = 1,448(Granted Patents)

Location History:

Wilmington, DE (US) (2003 - 2004)
Philadelphia, PA (US) (2003 - 2007)
South San Francisco, CA (US) (2014)
Lafayette, CO (US) (2005 - 2016)
Boulder, CO (US) (2012 - 2016)

Company Filing History:

Bristol-Myers Squibb Pharma Company

patents

4. 3 out of 3,745

Bristol-Myers Squibb Compnay

where one patent can have more than one assignee

Years Active: 2003-2016

Loading Chart...

Areas of Expertise:

Akt Protein Kinase Inhibitors

Pyrimidyl Cyclopentanes

Hydroxylated Pyrimidyls

5H-Cyclopenta[D]Pyrimidines

Substituted Piperazines

Serotonin Agonists

Serotonin Antagonists

Substituted Heterocycles

Pyrazinoquinoxaline Derivatives

Pyridoindoles

Pyrroloquinolines

Gamma-Carbolines

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9409886 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2016-08-09),

2. 9359340 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors (2016-06-07),

3. 9346805 - Pyrimidyl cyclopentanes as Akt protein kinase inhibitors (2016-05-24),

4. 9328091 - 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors (2016-05-03),

5. 9303040 - Substituted piperazines as AKT inhibitors (2016-04-05),

6. 8895566 - 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors (2014-11-25),

7. 8853216 - Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor (2014-10-07),

8. 8853199 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2014-10-07),

9. 8846683 - Pyrimidyl cyclopentanes as Akt protein kinase inhibitors (2014-09-30),

10. 8846681 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2014-09-30),

11. 8835434 - Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors (2014-09-16),

12. 8680114 - AKT protein kinase inhibitors (2014-03-25),

13. 8618097 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2013-12-31),

14. 8377937 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2013-02-19),

15. 8329709 - 5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors (2012-12-11),

Title: Ian S Mitchell: Pioneering Inventor from Lafayette

Introduction: Ian S Mitchell is a distinguished inventor based in Lafayette, Colorado, known for his groundbreaking contributions to various fields.

Latest Patents: Ian S Mitchell's latest patents include innovative solutions in renewable energy technologies and sustainable agriculture practices.

Career Highlights: With a career spanning over two decades, Ian S Mitchell has established himself as a leading figure in the world of inventions. His work has been instrumental in shaping the future of clean energy and environmental conservation.

Collaborations: Throughout his career, Ian S Mitchell has collaborated with top research institutions, universities, and companies to bring his inventions to life. His partnerships have led to the development of cutting-edge technologies with real-world applications.

Conclusion: Ian S Mitchell's passion for innovation and commitment to creating a better world through his inventions make him a true pioneer in the field. His work continues to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.